PHIO
Phio Pharmaceuticals Corp
NASDAQ: PHIO · HEALTHCARE · BIOTECHNOLOGY
$1.22
+3.39% today
Updated 2026-04-30
Market cap
$13.94M
P/E ratio
—
P/S ratio
48.01x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$1 – $3
Volume
0.3M
Phio Pharmaceuticals Corp (PHIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.69M | $5.59M | $14.94M | $9.19M | $11.16M | $13.40M | $4.10M | $15.32M | $8.04M | $15.74M | $25.17M | $12.81M | $9.36M | $5.74M |
| Cash & equivalents | $503000.00 | $5.13M | $11.39M | $8.50M | $5.12M | $12.91M | $3.58M | $14.88M | $6.93M | $14.24M | $24.06M | $11.78M | $8.49M | $5.38M |
| Current assets | $1.34M | $5.39M | $14.74M | $8.99M | $10.98M | $13.11M | $3.83M | $15.15M | $7.30M | $15.16M | $24.73M | $12.45M | $9.32M | $5.74M |
| Total liabilities | $2.28M | $11.43M | $10.00M | $6.44M | $2.27M | $2.54M | $2.27M | $1.74M | $2.29M | $2.72M | $3.24M | $1.97M | $1.63M | $1.01M |
| Current liabilities | $1.78M | $1.68M | $2.08M | $1.33M | $2.27M | $2.54M | $2.27M | $1.74M | $1.88M | $2.20M | $3.07M | $1.94M | $1.63M | $1.01M |
| Long-term debt | — | — | — | — | — | — | — | — | — | $231000.00 | — | — | — | — |
| Shareholder equity | $-587000.00 | $-5.84M | $4.94M | $2.75M | $8.89M | $10.86M | $1.83M | $13.58M | $5.75M | $13.02M | $21.93M | $10.84M | $7.73M | $4.72M |
| Retained earnings | $-4.28M | $-17.16M | $-38.08M | $-46.88M | $-57.10M | $-66.10M | $-78.55M | $-85.91M | $-94.82M | $-103.61M | $-116.90M | $-128.38M | $-139.21M | $-146.36M |
| Accounts receivable | $597000.00 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — |